Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats

赛马鲁肽 伏隔核 药理学 酒精使用障碍 兴奋剂 内分泌学 内科学 多巴胺 刺激 医学 化学 受体 生物化学 糖尿病 2型糖尿病 利拉鲁肽
作者
Cajsa Aranäs,Christian E. Edvardsson,Olesya T. Shevchouk,Qian Zhang,Sarah Witley,Sebastian Blid Sköldheden,Lindsay Zentveld,Daniel Vallöf,Maximilian Tufvesson‐Alm,Elisabet Jerlhag
出处
期刊:EBioMedicine [Elsevier BV]
卷期号:93: 104642-104642 被引量:55
标识
DOI:10.1016/j.ebiom.2023.104642
摘要

Glucagon-like peptide1 receptor (GLP-1R) agonists have been found to reduce alcohol drinking in rodents and overweight patients with alcohol use disorder (AUD). However, the probability of low semaglutide doses, an agonist with higher potency and affinity for GLP-1R, to attenuate alcohol-related responses in rodents and the underlying neuronal mechanisms is unknown.In the intermittent access model, we examined the ability of semaglutide to decrease alcohol intake and block relapse-like drinking, as well as imaging the binding of fluorescently marked semaglutide to nucleus accumbens (NAc) in both male and female rats. The suppressive effect of semaglutide on alcohol-induced locomotor stimulation and in vivo dopamine release in NAc was tested in male mice. We evaluated effect of semaglutide on the in vivo release of dopamine metabolites (DOPAC and HVA) and gene expression of enzymes metabolising dopamine (MAOA and COMT) in male mice.In male and female rats, acute and repeated semaglutide administration reduced alcohol intake and prevented relapse-like drinking. Moreover, fluorescently labelled semaglutide was detected in NAc of alcohol-drinking male and female rats. Further, semaglutide attenuated the ability of alcohol to cause hyperlocomotion and to elevate dopamine in NAc in male mice. As further shown in male mice, semaglutide enhanced DOPAC and HVA in NAc when alcohol was onboard and increased the gene expression of COMT and MAOA.Altogether, this indicates that semaglutide reduces alcohol drinking behaviours, possibly via a reduction in alcohol-induced reward and NAc dependent mechanisms. As semaglutide also decreased body weight of alcohol-drinking rats of both sexes, upcoming clinical studies should test the plausibility that semaglutide reduces alcohol intake and body weight in overweight AUD patients.Swedish Research Council (2019-01676), LUA/ALF (723941) from the Sahlgrenska University Hospital and the Swedish brain foundation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
冬日空虚应助七七爱学习采纳,获得10
刚刚
无花果应助Yang采纳,获得10
1秒前
FAHUO完成签到,获得积分10
1秒前
ning发布了新的文献求助10
1秒前
1秒前
拼搏的黑夜完成签到,获得积分10
1秒前
大力的一手完成签到,获得积分10
1秒前
Hello应助Owen采纳,获得10
2秒前
3秒前
动听的谷秋完成签到,获得积分10
3秒前
3秒前
4秒前
ovalCC完成签到,获得积分10
4秒前
SciGPT应助细腻天蓝采纳,获得10
4秒前
4秒前
科目三应助马梦乐采纳,获得10
4秒前
吱吱吱吱发布了新的文献求助10
4秒前
顺顺黎黎完成签到,获得积分10
4秒前
5秒前
路人发布了新的文献求助10
5秒前
不吃鸭梨完成签到,获得积分10
5秒前
涣醒完成签到,获得积分10
6秒前
Lee完成签到,获得积分10
6秒前
ZJK完成签到,获得积分10
6秒前
caicai发布了新的文献求助10
6秒前
6秒前
龙猫完成签到 ,获得积分10
7秒前
马耳完成签到,获得积分10
7秒前
泥蝶完成签到 ,获得积分10
7秒前
披萨好吃酱完成签到,获得积分10
8秒前
8秒前
糖豆完成签到,获得积分10
8秒前
zmy完成签到,获得积分10
9秒前
9秒前
逆天了呀完成签到,获得积分10
9秒前
无心科研完成签到,获得积分10
9秒前
苏震坤发布了新的文献求助10
9秒前
crazy完成签到 ,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6952646
求助须知:如何正确求助?哪些是违规求助? 8636743
关于积分的说明 18313933
捐赠科研通 6395855
什么是DOI,文献DOI怎么找? 3082462
关于科研通互助平台的介绍 2128093
邀请新用户注册赠送积分活动 2059351